Extracellular Vesicles in Triple–Negative Breast Cancer: Immune Regulation, Biomarkers, and Immunotherapeutic Potential

Keyphrases

• Immune Regulation 100%
• Immunotherapeutics 100%
• Extracellular Vesicles 100%
• Triple-negative Breast Cancer 100%
• Anticancer Immune Response 100%
• Breast Cancer Treatment 16%
• Immunogenic 8%
• Estrogen Receptor 8%
• Molecular Targets 8%
• MicroRNA 8%
• Immune System 8%
• Diagnostic Biomarker 8%
• Treatment Modalities 8%
• Complex Interplay 8%
• Breast Cancer Progression 8%
• Targeted Therapy 8%
• Immunotherapeutic Strategy 8%
• Response Rate 8%
• Systemic Treatment 8%
• Molecular Profile 8%
• Epidermal Growth Factor Receptor 8%
• Progesterone Receptor 8%
• Novel Drug Delivery System 8%
• Predictive Biomarker 8%
• Targeted Immunotherapy 8%
• Chemotherapy Efficacy 8%
• Current Clinical Practice 8%
• Endocrine Therapy 8%
• Chemotherapeutic Regimens 8%
• Emerging Resistance 8%
• Bioactive Molecules 8%
• Immune Checkpoint Inhibitors 8%
• Lipid-DNA 8%
• Aggressive Subtypes 8%
• Mutational Burden 8%
• Human Epidermal Growth Factor Receptor 2 Amplification 8%

Biochemistry, Genetics and Molecular Biology

• Immunoregulation 100%
• Estrogen Receptor 50%
• Lipid 50%
• Epidermal Growth Factor Receptor 50%
• Progesterone Receptor 50%
• Cancer Immunotherapy 50%
• Immune Checkpoints 50%
• Diagnostic Biomarker 50%
• Targeted Therapy 50%

Immunology and Microbiology

• Immunoregulation 100%
• Immunotherapy 100%
• Cancer Immunotherapy 50%
• Gamma Urogastrone 50%
• Immune System 50%